Article
A nanowire-based liquid biopsy method using cerebrospinal fluid cell-free DNA for targeted management of leptomeningeal carcinomatosis.
Journal of cancer research and clinical oncology - 1 Jan 2021
Choi Wonyoung, Cho Youngnam, Park Seog-Yun, Hwang Kum Hui, Han Ji-Youn, Lee Youngjoo
Abstract excerpt
PURPOSE: This study aimed to evaluate whether genotyping cell free DNA (cfDNA) in the cerebrospinal fluid (CSF) may be helpful in managing leptomeningeal carcinomatosis (LMC) of EGFR-mutant non-small cell lung cancer (NSCLC). METHODS: Patients with EGFR-mutant NSCLC who progressed as LMC after 3rd-generation tyrosine kinase inhibitors (EGFR-TKIs) were evaluated. A nanowire-based cfDNA assay was performed for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
